Chrysalis BioTherapeutics Receives Funding from the National Institutes of Health for COVID-19 Therapeutic Development
Amount Raised
$912
Round Type
Pre-Seed
GalvestonBiotechnologyHealthcareDescription
Chrysalis BioTherapeutics, Inc., a clinical-stage biotechnology company developing regenerative drugs for acute organ injury caused by radiation exposure, announced today that the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health, awarded Chrysalis $912,157 to fund preclinical development of its investigational drug TP508 for SARS-CoV-2 infection. The contract award includes an option to conduct a Phase I human clinical trial to demonstrate safety prior to initiating efficacy trials in COVID-19 patients.
Quick answer
Chrysalis Bio Therapeutics raised $912 in a Pre-Seed round, dated June 10, 2020. Chrysalis Bio Therapeutics is based in Galveston, Texas, United States.
- How much did Chrysalis Bio Therapeutics raise?
- Chrysalis Bio Therapeutics raised $912 in a Pre-Seed round on June 10, 2020.
- What does Chrysalis Bio Therapeutics do?
- Chrysalis BioTherapeutics, Inc. is a biopharmaceutical development company located in Galveston, TX.
- Where is Chrysalis Bio Therapeutics based and how big is it?
- Chrysalis Bio Therapeutics is based in Galveston, Texas, United States.
- Who are the decision-makers at Chrysalis Bio Therapeutics?
- Fundz holds 2 contacts at Chrysalis Bio Therapeutics, including the CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Chrysalis Bio Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Revalesio raised $20M on July 22, 2020.
- TriFlo Cardiovascular Inc raised $4.6M (Seed) on July 22, 2020.
- CurvaFix raised $10M (Series B) on July 21, 2020.
- Aspira Women’s Health raised $11M on July 15, 2020.
- valisure llc raised $3.8M (Seed) on July 14, 2020.
- Elite Pharmaceuticals raised $500K (Seed) on July 13, 2020.
Who to call at Chrysalis Bio Therapeutics, and when
A new round usually means Chrysalis Bio Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Chrysalis Bio Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Chrysalis Bio Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Chrysalis Bio Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Chrysalis Bio Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Chrysalis Bio Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.